The purpose of this study is to evaluate the safety of the drug ursodiol (ursodeoxycholic
acid, UDCA) in people with Huntington's disease (HD) and to explore how the compound is
processed by the body.
Phase:
Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
Huntington Society of Canada Huntington Study Group